Related Experiment Video

Updated: Aug 7, 2026

Identification of Kinase-substrate Pairs Using High Throughput Screening
11:13

Identification of Kinase-substrate Pairs Using High Throughput Screening

Published on: August 29, 2015

Genomic loci of human mitogen-activated protein kinases

L Li1, M Wysk, F A Gonzalez

  • 1Howard Hughes Medical Institute, Worcester, Massachusetts.

Oncogene
|February 1, 1994
PubMed

Insights

Mitogen-activated protein (MAP) kinases are crucial for cell signaling and can be oncogenic. This study maps the human genome locations for three key MAP kinase genes, identifying their distribution in chromosomes.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Mitogen-activated protein (MAP) kinases, also known as Extracellular signal-regulated kinases (Erks), are vital signal transduction mediators for growth factor receptors.
  • Aberrant activation of MAP kinase pathway components, including growth factor receptors, Ras, and Raf, is implicated in malignant tumors.
  • MAP kinase genes are therefore potential targets for carcinogenic mutations.

Purpose of the Study:

  • To determine the genomic loci of three MAP kinase genes within the human genome.
  • To investigate the chromosomal distribution of these potentially oncogenic genes.

Main Methods:

  • Human genome mapping techniques were employed.
  • Specific genomic locations for three MAP kinase genes were identified.

Main Results:

  • The genomic locus for p41mapk (Erk2) was mapped to chromosome 22q11.2.
  • The genomic locus for p44mapk (Erk1) was mapped to chromosome 16p11.2.
  • The genomic locus for p63mapk (an Erk3-related gene) was mapped to chromosomes 18q12-21.

Conclusions:

  • The genes encoding MAP kinases are widely distributed across the human genome.
  • Understanding the genomic locations of these genes is crucial for cancer research and identifying potential oncogenic targets.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment07:55

Subcellular Fractionation for ERK Activation Upon Mitochondrial-derived Peptide Treatment

Published on: September 25, 2017

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...